Evaluation of Biomarker Expression in Diabetic and Healthy Subjects Over a One Year Period

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

61 participants

Study Classification

OBSERVATIONAL

Study Start Date

2013-07-31

Study Completion Date

2015-10-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This study is conducted in the United States of America (USA). The aim of this study is to assess longitudinal variation of immune biomarkers in subjects with type 1 diabetes (T1D), type 2 diabetes (T2D) and healthy, non-diabetic subjects over a one year period.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Metabolic Phenotypes and Heterogeneity in Disease Burden Risk in Type 1 Diabetes

NCT05609279

Diabetes Mellitus

COMPLETED

Clinical Characteristics of People With Long-term Type 1 Diabetes

NCT05359796

Type 1 Diabetes

RECRUITING

A Study of Blood Metabolic Markers in Patients With Type 2 Diabetes Mellitus of Different Stages

NCT06155539

Diabetes Mellitus, Type 2

NOT_YET_RECRUITING

The Prevalence of Autoimmune Antibodies in Patients with Type 2 Diabetes Managed by Endocrinology Vs. Primary Care

NCT05553145

Type 2 Diabetes

COMPLETED

Cohort Study of Patients With Type 1 Diabetes

NCT03610984

Type 1 Diabetes Mellitus Structured Education

COMPLETED

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Diabetes Diabetes Mellitus, Type 1 Diabetes Mellitus, Type 2 Healthy

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

All participants

No treatment given

Intervention Type OTHER

The participants will not receive any treatment

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

No treatment given

The participants will not receive any treatment

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* T1D
* Male or female subjects diagnosed within the last 3 years and with good general health based on medical history
* Age above or equal to 14 years and below or equal to 40 years
* Body weight above 45 kg
* T2D
* Male or female subjects diagnosed within the last 15 years with good general health based on medical history
* HbA1c between 6.5% and 10%
* Body mass index (BMI) below 45 kg/m\^2
* Age above or equal to 18 and below 65 years
* On insulin treatment
* HS
* Male or female subjects with good general heath based on medical history
* Age above or equal to 18 years and below or equal to 40 years

Exclusion Criteria

* Any chronic disorder (besides T1D or T2D) or severe disease which, in the opinion of the investigator, might jeopardize subject's safety or compliance with the protocol
* Female of child-bearing potential who is pregnant, breast-feeding, or intends to become pregnant

Minimum Eligible Age

14 Years

Maximum Eligible Age

40 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes